Tissue Regenix Group plc (LON:TRX – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 60.55 ($0.75) and traded as low as GBX 57 ($0.70). Tissue Regenix Group shares last traded at GBX 57 ($0.70), with a volume of 18,582 shares.
Tissue Regenix Group Stock Down 2.6 %
The stock has a market capitalization of £40.60 million, a price-to-earnings ratio of -5,700.00 and a beta of 1.61. The business has a 50-day moving average of GBX 58.80 and a 200-day moving average of GBX 60.53. The company has a debt-to-equity ratio of 35.69, a quick ratio of 2.36 and a current ratio of 3.74.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Why Invest in High-Yield Dividend Stocks?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Why Are These Companies Considered Blue Chips?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Stock Market Upgrades: What Are They?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
